Series C funding round for Bluejay Therapeutics raising $180M in May 2024
Series C funding round for Bluejay Therapeutics raising $180M in May 2024
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Eric Shiozaki |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$221M
Top Valuation
-
Bluejay Therapeutics raised $180M in a Series C round.
The round was announced on 05/01/24.
The round was led by Daniel Estes.